The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-([1,1'-biphenyl]-4-ylmethyl)-7-(3-carbamoylpyrrolidin-1-yl)-6-fluoro-8-methoxy-4-oxo-1,4dihydroquinoline-3-carboxylic acid ID: ALA4475343
PubChem CID: 134603935
Max Phase: Preclinical
Molecular Formula: C29H26FN3O5
Molecular Weight: 515.54
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1c(N2CC[C@@H](C(N)=O)C2)c(F)cc2c(=O)c(C(=O)O)cn(Cc3ccc(-c4ccccc4)cc3)c12
Standard InChI: InChI=1S/C29H26FN3O5/c1-38-27-24-21(13-23(30)25(27)32-12-11-20(15-32)28(31)35)26(34)22(29(36)37)16-33(24)14-17-7-9-19(10-8-17)18-5-3-2-4-6-18/h2-10,13,16,20H,11-12,14-15H2,1H3,(H2,31,35)(H,36,37)/t20-/m1/s1
Standard InChI Key: KKNRMJZKPRRTNJ-HXUWFJFHSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
4.0185 -9.0303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0174 -9.8499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7254 -10.2588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7236 -8.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4322 -9.0267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4311 -9.8474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1373 -10.2564 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8492 -9.8494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8503 -9.0287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1396 -8.6151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1396 -7.7980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5590 -8.6219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2657 -9.0322 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5610 -7.8047 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1350 -11.0736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8416 -11.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8379 -12.3002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5436 -12.7107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2535 -12.3040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2531 -11.4826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5468 -11.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9588 -12.7118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9563 -13.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6625 -13.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3718 -13.5321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3704 -12.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6635 -12.3048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7271 -11.0760 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.0202 -11.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3093 -10.2579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3107 -8.6219 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5616 -9.9264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0143 -10.5333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4224 -11.2413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2218 -11.0719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2010 -10.4465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8692 -9.6997 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7193 -11.1084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
7 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
19 22 1 0
3 28 1 0
28 29 1 0
2 30 1 0
1 31 1 0
30 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 30 1 0
36 37 2 0
36 38 1 0
33 36 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.54Molecular Weight (Monoisotopic): 515.1856AlogP: 3.87#Rotatable Bonds: 7Polar Surface Area: 114.86Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.05CX Basic pKa: ┄CX LogP: 3.82CX LogD: 2.45Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.39Np Likeness Score: -0.79
References 1. Delgado JL, Lentz SRC, Kulkarni CA, Chheda PR, Held HA, Hiasa H, Kerns RJ.. (2019) Probing structural requirements for human topoisomerase I inhibition by a novel N1-Biphenyl fluoroquinolone., 172 [PMID:30959322 ] [10.1016/j.ejmech.2019.03.040 ]